Hep B Press Releases
The Hepatitis B Foundation is happy to assist journalists who are reporting on the impact of hepatitis B worldwide and related issues. We can help set up interviews with experts in research, public health, community outreach efforts and immunization and treatment initiatives.
News media contacts:
- Ed Tate, chief communications officer, edward.tate@hepb.org, 267-934-3475
- Monique Benvenutti, communications & social media manager, monique.benvenutti@hepb.org, 215-489-4900
.......................................................................................
Making a major investment to fight hepatitis B in Africa
The Hepatitis B Foundation has launched a major new, multiyear program to support hepatitis B elimination initiatives across Africa. Please read more here.
Taiwanese scientist conducting influential hepatitis research to receive the 2025 Baruch S. Blumberg Prize
The Hepatitis B Foundation announced that Pei-Jer Chen, MD, PhD, a Distinguished Investigator at the National Taiwan University and globally recognized expert on liver diseases, has been chosen to receive its 2025 Baruch S. Blumberg Prize. Dr. Chen is a clinician, scientist and advocate for people living with hepatitis B. Please read more here.
Eight prominent clinicians and researchers join Hepatitis B Foundation Scientific and Medical Advisory Board
The Scientific and Medical Advisory Board provides the Hepatitis B Foundation and Baruch S. Blumberg Institute with strategic guidance and direction for our research, advocacy and scientific programs. The Board also provides input in the creation of public affairs and policy positions the institutions take. Please read more here.
FDA action increases the prospect for bringing hepatitis B screening one step closer to those who lack access to care
A potentially significant public health tool, POC testing has been used in Europe and Asia for years.
The U.S. Food and Drug Administration (FDA) recently posted a proposed rule, “Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices,” down-classifying hepatitis B screening and diagnostic tests from class III to class II. This increases the likelihood that point-of-care (POC) testing for hepatitis B in the U.S. will be made available, which is instrumental to improving access to testing for the disease. Please read more here.
Efforts to combat hepatitis B across the U.S. and globally discussed in a recent Chicago forum
Held at the world's primary scientific conference on hepatitis B, the event focused on the 300 million people worldwide living with the disease. Please read more here.
Hepatitis B Foundation to hold community event to celebrate new book by a co-founder
Timothy M. Block, PhD, will share his thoughts about launching the Foundation, Blumberg Institute and Pennsylvania Biotechnology Center (PABC).
Dr. Block will give a presentation about the book and the stories it offers, and sign copies, at a community event at 4 p.m. on Sept. 26 at the PABC, 3805 Old Easton Road, Doylestown, 18902. Please read more here.
Hepatitis B Foundation hosts B Informed Patient Conference
The event brought together participants from around the Philadelphia region.
The Hepatitis B Foundation hosted its B Informed Patient Conference in Philadelphia on July 27, a day before World Hepatitis Day, for people living with hepatitis B, clinicians treating them and public health experts engaged in the field. Please read more here.
WHO announces new guidelines for treatment of hepatitis B
A webinar about the guidelines co-hosted by the WHO and Hepatitis B Foundation is set for April 17.
The Hepatitis B Foundation is pleased to share the news that the World Health Organization (WHO) has released new “Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.” The new guidelines were released today (March 29) at the annual meeting of the Asian Pacific Association for the Study of the Liver (APASL) in Kyoto, Japan. Please read more here.
People living with hepatitis B should have a voice in new treatment guidelines, advocates say
A widely read medical journal, The Lancet Gastroenterology & Hepatology, published a commentary on Jan. 22 from a team of physicians and public health experts who strongly advocate for patients’ voices to be heard in developing new guidelines for people living with hepatitis B. A webinar for health care providers and public health professionals on the need for the lived experience to be included in guideline development and incorporating the patients’ voice is set for Feb. 15 at 10 a.m. EST. Please read more here.
Hepatitis B Foundation presents globally recognized expert on liver disease with 2024 Baruch S. Blumberg Prize
At its April 5 Gala, the Hepatitis B Foundation presented T. Jake Liang, MD, a Distinguished Investigator at the National Institutes of Health and globally recognized expert on liver diseases, with the 2024 Baruch S. Blumberg Prize. “The community owes a tremendous debt of gratitude to Dr. Liang for his decades of contributions to the basic science advances and clinical care of those with chronic hepatitis B,” Hepatitis B Foundation President Chari A. Cohen, DrPH, MPH, said. Read more here.
Hepatitis B Foundation launches training website with user-friendly courses for everyone interested in hepatitis B and D
The Hepatitis B Foundation and partners are launching a cost-free training website, the “B Informed Training Hub,” for people who want to learn more about hepatitis B and hepatitis D. The online tool was developed by the Hepatitis B Foundation, working in collaboration with HepBCommunity and the Westmead Institute for Medical Research. Please read more here.
Pennsylvania couple to receive Hepatitis B Foundation’s Community Leadership Award
The Hepatitis B Foundation announced today that Catharine and Rob Williams, who reside in Strafford, Pa., have been chosen to receive the Foundation’s Community Leadership Award for 2024. They will be honored on April 5 at the organization’s Annual Gala. Please read more here.
Hepatitis B Foundation, Blumberg Institute and PABC congratulates John Crowley of Amicus on being named BIO President and CEO
Louis P. Kassa III, MPA, CEO of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), today described the choice of John F. Crowley, JD, MBA, executive chairman, Amicus Therapeutics, to be president and CEO of BIO, as “a brilliant decision that produce tangible benefits to the biotech industry.” Please read more here.
Hepatitis B Foundation extends its engagement in Africa
The Hepatitis B Foundation extended its engagement in Africa this fall with staff participating in two major, influential conferences: the Conference on Liver Disease in Africa (COLDA), held in Dar es Salaam, Tanzania, in September and the African Hepatitis Summit in Abuja, Nigeria in October. Please read more here.
Sen. Steven J. Santarsiero honored at the Pennsylvania Biotechnology Center (PABC)
The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) presented Sen. Steven J. Santarsiero, who represents residents of Bucks County, with the organizations’ first annual Timothy M. Block, PhD, Biotech Impact Award.” Please read more here.
Hepatitis B Foundation invites providers and public to participate in The Liver Meeting, Nov. 10-14, in Boston and online
The Hepatitis B Foundation invites patient advocates, clinicians, and people living with hepatitis B, hepatitis D, or other liver disease, to participate in a special patient forum, online or in-person, Nov. 10 at The Liver Meeting. Read more here.
Hepatitis B Foundation coordinates 2023 International HBV Meeting, an annual scientific conference held Sept. 19-23 in Kobe, Japan
The Hepatitis B Foundation coordinated the highly successful 2023 International HBV Meeting, held Sept. 19-23 in Kobe, Japan. Read more here.
Gala puts the spotlight on creating family and support for those living with hepatitis B
The Hepatitis B Foundation Annual Gala honored two global leaders in the fight to advance hepatitis B science, prevention and treatment. The Foundation held its annual Gala, a fundraiser that celebrates the nonprofit’s people and achievements, on March 10 at The Warrington, a popular venue in Warrington, Pa. Read more here.
Global leader, New Jersey physician treating people living with hepatitis B takes new role with Hepatitis B Foundation
Su Wang, MD, MPH, FACP, a prominent leader in the global hepatitis community and a member the Hepatitis B Foundation’s Board of Directors, has become the Foundation’s first Senior Advisor for Global Health. Please read more here.
Hepatitis B Foundation releases white paper calling health care providers into action following new hepatitis B screening and vaccination recommendations
With the U.S. Centers for Disease Control and Prevention (CDC) release last week of new guidance for hepatitis B screening, adding to updated recommendations on vaccination that the CDC put out last spring, the Hepatitis B Foundation has produced a white paper with guidance on how health care providers in the U.S. can begin implementing these new universal hepatitis B screening and vaccination (for adults ages 19-59) guidelines. Please read more here.
New CDC Universal Screening Recommendations will save lives, Hepatitis B Foundation President Dr. Chari Cohen says
New guidance released today by the U.S. Centers for Disease Control and Prevention (CDC) that recommend testing of all adults ages 18 and older will save lives, ultimately, says Hepatitis B Foundation President Chari A. Cohen, DrPH, MPH. Read more here.
Louis P. Kassa III, CEO of the Hepatitis B Foundation, Blumberg Institute and Pennsylvania Biotechnology Center named to Philadelphia’s Power 101
Louis P. Kassa III, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) was chosen by the Philadelphia Business Journal for its Power 101 list, which is being released this week. Read more here.
Hepatitis B Foundation president responds to Janssen decision on the company’s hepatitis B drug development program
The Johnson & Johnson subsidiary is ending efforts produce a treatment for hepatitis B, a life-threatening infection that impacts 300 million people worldwide. Hepatitis B Foundation President Chari A. Cohen, DrPH, MPH, today expressed frustration that Janssen has decided to shutdown its program to develop a drug to treat hepatitis B, which is incurable and infects millions in the U.S. and globally. Read more here.
Globally prominent advocate and physician chosen for Hepatitis B Foundation’s 2023 Community Commitment Award
The Hepatitis B Foundation, a global nonprofit organization based in Doylestown, Pa., has chosen Su Wang, MD, MPH, FACP, dedicated physician and advocate, to receive the Foundation’s 2023 Community Commitment Award. Read more here.
Dr. Yasmin Ibrahim appointed to national Patient Engagement Collaborative
The U.S. Food and Drug Administration and the Clinical Trials Transformation Initiative (CTTI) has announced eight newly selected representatives for the Patient Engagement Collaborative, including Yasmin Ibrahim, MD, PhD, MBA, of the Hepatitis B Foundation. Read more here.
Comprehensive hepatitis B program in Vietnam provides an excellent model for other countries
A comprehensive program in Vietnam connected to Johns Hopkins University that we support is developing a highly effect model for eliminating hepatitis B in a hig-prevalence area. Please read more here.
Open letter to Gavi urging them to start their hepatitis B birth dose campaign
The Hepatitis B Foundation has signed on to an open letter to Gavi, the Vaccine Alliance, urging them to start their hepatitis B birth dose campaign. Read the open letter in The Lancet here.
Hepatitis B Foundation announces third series of continuing education series on hepatitis B for health care providers and public health professionals
The Hepatitis B Foundation launched Hep B Project ECHO in 2021, and the program is now gearing up for a third series. This free CME continuing education series for health care providers and public health professionals uses the ECHO Model™ to deliver educational content about hepatitis B to physicians, nurses, pharmacists, public health coordinators, medical students/fellows and other health care professionals. Read more here.
Hepatitis B Foundation hails decision by U.S. Public Health Service Corps to accept future applicants living with chronic hepatitis B infection and HIV
The Hepatitis B Foundation applauds the decision of the U.S. Public Health Service Commissioned Corps to accept future applicants living with chronic hepatitis B infection and HIV. The USPHS Commissioned Corps announced the change yesterday (Dec. 1), which was World AIDS Day. Previously, HIV and hepatitis B infection were both considered disqualifying medical conditions. This new decision reflects the latest scientific evidence and opens the door for applicants with hepatitis B and HIV to serve as uniformed Public Health Service officers. Read more here.
German scientist, inventor of world’s first treatment for hepatitis D, to receive the 2023 Baruch S. Blumberg Prize
The Hepatitis B Foundation, a global nonprofit organization, today announced that Stephan Urban, PhD, distinguished professor and globally recognized virologist, has been chosen to receive its 2023 Baruch S. Blumberg Prize. Read more here.
Researchers and people living with hepatitis B meet in Paris at the third Hepatitis B Community Forum
The perspectives of the almost 300 million people living with hepatitis B is critical as scientists and clinicians continue working toward hepatitis B cure and elimination, which was the focus of a special session that concluded the 2022 International HBV Meeting. Read more here.
Hepatitis B Foundation mourns Bill Mason, an accomplished scientist whose discovery led to current treatments for hepatitis B
The Hepatitis B Foundation mourns the loss of William S. Mason, PhD, an internationally influential scientist dedicated to the study of hepatitis B and longtime friend of the Hepatitis B Foundation, who passed away Sept. 19. Read more here.
Hepatitis B Foundation raises alarm about findings from new federal viral hepatitis surveillance report
A new CDC report shows major COVID-related disruptions in hepatitis B testing and significant health equity concerns about the virus’ impact on the Asian American/Pacific Islander community. Read more here.
Hepatitis B Foundation strongly supports Congressional letters urging Biden administration to end discriminatory military policy
The Hepatitis B Foundation, which has long fought against discrimination of people living with hepatitis B, strongly supports a new effort to permit individuals with hepatitis B or HIV to serve in the U.S. military. Please read more here.
Report from Washington: Hepatitis B Foundation Requested Language Included in FY2023 House and Senate Appropriation Reports
The Hepatitis B Foundation’s policy team spends considerable time and effort each year to increase federal prioritization and advocate for funding for hepatitis B and liver cancer research and public health programming. Please read the full report here.
Two Global Community Advisory Boards launched by the Hepatitis B Foundation
To further its work as the world’s leading nonprofit dedicated to hepatitis B and liver cancer, the Hepatitis B Foundation has formed two new Global Community Advisory Boards. At the Foundation’s invitation, 81 people worldwide, primarily people living with hepatitis B and delta infections, applied to serve on the advisory boards. Please read more here.
Longtime Board Chair honored by his colleagues
The Hepatitis B Foundation's Board of Directors and leadership recognized Joel D. Rosen, Esq., at the board's recent meeting for his nearly two decades of service. A board member since 2003, he was chair of the board from 2009 until stepping down last month. Read more here.
Dr. Chari A. Cohen becomes president of the Hepatitis B Foundation
Chari A. Cohen, DrPH, MPH, today (July 1) became president of the Hepatitis B Foundation, a global nonprofit organization based in Doylestown, Pa. Timothy M. Block, PhD, founding president of the organization, is now executive chair of the Foundation's Board of Directors. Please read more here.
Department of Health Highlights the Importance of Viral Hepatitis Awareness, Need for Expansion of Syringe Services
The Pennsylvania Department of Health joined advocates and residents with lived experiences to highlight the importance of viral hepatitis awareness along with the success of syringe services programs. Read this Pennsylvania Pressroom release here.
Hepatitis B Foundation, StoryCenter release new #justB stories from people with lived experience
For Hepatitis Awareness Month, the Hepatitis B Foundation has released five new videos as part of its national #justB storytelling campaign, which conveys the powerful stories of real people affected by hepatitis B. Read more here.
Hepatitis outbreaks among children in the U.S. and Europe
Pediatric hepatitis outbreaks in the U.S, and several European countries over the past few weeks and months have raised new concerns as a number of children have suffered liver damage (liver inflammation, or “hepatitis”) after becoming ill. Please read more here.
Philadelphia City Council recognizes May as Hepatitis Awareness Month
The Hepatitis B Foundation and Hep B United Philadelphia applaud the City of Philadelphia’s Resolution that recognizes May as Hepatitis Awareness Month. Please read more here.
Hepatitis B Foundation hosts Princeton Workshop on Liver Cancer
The Hepatitis B Foundation hosted more than 30 top scientists and physicians from across the U.S. for a day-long meeting April 28 on "Liver Cancer Risk, Prevention and Early Detection: Challenges and Opportunities to Improve Outcomes." Please read more here.
Annual Gala raises a record amount for the local Hepatitis B Foundation
Doylestown, Pa., April 27, 2022 – The Hepatitis B Foundation Gala, an annual fundraiser and celebration of the nonprofit’s people and achievements, was held on April 1 at The Warrington, a popular event venue in Warrington, Pa. Gilead Sciences Inc. was the presenting sponsor of this record-breaking event. Read more here.
Hepatitis D Roundtable to Address Unmet Needs of Patients
Fairfield, NJ—April 21, 2022—The American Liver Foundation (ALF) and Hepatitis B Foundation will join forces with key stakeholders concerned with identifying and addressing the unmet needs of people living with hepatitis D virus (HDV). Read more here.
DiRx partners with Hepatitis B Foundation to offer low-cost medications
East Brunswick, New Jersey, April 14, 2022 - Hepatitis B Foundation, a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B, is the newest partner of DiRx, a fast-growing digital pharmacy platform focused on generic medicine access and affordability. Hepatitis B is the most common serious liver infection in the world, and a 2021 study estimated that as many as 2.4 million people in the U.S. live with hepatitis B. Please read more here.
Many more U.S. adults to get vaccinated against hepatitis B following move by CDC
Doylestown, Pa., April 1, 2022 – The Hepatitis B Foundation enthusiastically endorses the adoption of new adult vaccination guidelines for hepatitis B by the U.S. Centers for Disease Control and Prevention (CDC), and the Foundation is organizing a group of experts to help with implementation to ensure millions more U.S. adults get vaccinated against the dangerous virus. Please read more here.
Hepatitis B Foundation receives Congressional funding for a Center of Public Health Excellence
Doylestown, Pa., March 14, 2022 – With the passage of the Fiscal Year 2022 Omnibus Appropriations Act, the Hepatitis B Foundation will receive $475,000 to create a Center of Public Health Excellence focused on hepatitis B elimination by providing expert resources, advice, training, capacity building and technical assistance for state and local partners including health departments, social service organizations, and community-based health providers on how to best prevent, treat and control hepatitis B and to increase the rate of adult vaccination and testing for hepatitis B. Read more here.
CTC Foundation of Princeton donating $100,000 to Hepatitis B Foundation
Doylestown, Pa., Feb. 3, 2022 – The CTC Foundation of Princeton, N.J., is donating $100,000 over five years to the Hepatitis B Foundation, a global nonprofit organization that is engaged in advocacy, education and research to combat hepatitis B, the most common serious liver infection in the world. Read more here.
Hepatitis B Foundation senior vice president and board member speak on popular podcast
Doylestown, Pa., Jan. 27, 2022 – A leading science podcast currently is focusing on hepatitis B, and the two experts interviewed are Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, and Su Wang, MD, MPH, FACP, a member of the Foundation’s Scientific and Medical Advisory Board and its Board of Directors. Read more here.
Anonymous donor provides record gift for hepatitis B research
Doylestown, Pa., Jan. 12, 2022 – A very generous Florida couple who wishes to remain anonymous has contributed $500,000 to the Baruch S. Blumberg Institute, the research arm of the Hepatitis B Foundation, to advance research toward a cure for hepatitis B, the most common serious liver infection in the world. Read more here.
Two hepatitis B medications available free through Hepatitis B Foundation and Rx Outreach partnership
St. Louis, Dec. 6, 2021 — Two national nonprofit organizations have announced a new venture to provide two of the most commonly prescribed medications for chronic hepatitis B at no cost to people in need. Hundreds of people across the country are expected to benefit from the program. Read more here.
Canadian scientist chosen for the 2022 Hepatitis B Foundation’s Blumberg Prize
Doylestown, Pa., Nov. 22, 2021 – The Hepatitis B Foundation, a global nonprofit organization, today announced that D. Lorne Tyrrell, MD, PhD, Distinguished University Professor in the Department of Medical Microbiology and Immunology and the University of Alberta, has been chosen as the recipient of its 2022 Baruch S. Blumberg Prize for outstanding contributions to advance the science and medicine of hepatitis B. Read more here.
Doylestown native creates Sunrise Educational Fund to support high school and college students enrolled in Blumberg Institute programs
Doylestown, Pa., Nov. 8, 2021 – Baruch S. Blumberg Institute President Timothy M. Block today announced the establishment of The Sunrise Educational Fund, an endowment to support the Institute’s academic and experiential learning programs for high school and college students. Read more here.
Landmark vote by CDC’s Advisory Committee on Immunization Practices (ACIP) to recommend universal hepatitis B vaccination
Doylestown, Pa., Nov. 4, 2021 - The Hepatitis B Foundation applauds yesterday’s landmark vote by the Advisory Committee on Immunization Practices (ACIP) to recommend universal hepatitis B vaccination for all adults ages 19 to 59 in the U.S. Read more here.
Hepatitis B Foundation strongly endorses the Liver Illness Visibility, Education and Research (LIVER) Act of 2021
Oct. 22, 2021 – Introduced in the U.S. Senate (S.3041) by Sen. Tammy Duckworth (D-IL) and in the House (H.R.5675) by Rep. Nydia Velazquez (D-NY), the bill takes bold steps to increase investments in research, prevention and awareness activities to address hepatitis B, which kills an estimate 820,000 annually, and to address liver cancer, which continues to grow in incidence and is the second deadliest cancer. Read more here.
Hepatitis B Foundation Board of Directors selects Dr. Chari Cohen to succeed Dr. Timothy Block as president
Sept. 27, 2021 – The Hepatitis B Foundation, a global nonprofit organization based in Doylestown, Pa., today announced that Chari Cohen, DrPH, MPH, senior vice president, will become president of the Foundation, effective July 2022. Read more here.
New president announced for the Pennsylvania Biotechnology Center (PABC)
Sept. 27, 2021 – Louis P. Kassa, executive vice president and chief operating officer of the nonprofit Pennsylvania Biotechnology Center (PABC), will become the center’s president in July 2022. Read more here.
Major successes on Capitol Hill
Aug. 26, 2021 – A key aspect of the Hepatitis B Foundation’s efforts to eradicating hepatitis B is advocacy, particularly trying to educate and influence members of the U.S. Congress and their staffs. Please read more here.
CDC awards $1.375 million, 5-year grant to Hepatitis B Foundation for expansion of Hep B United
Aug. 13, 2021 – The U.S. Centers for Disease Control and Prevention has awarded a $1.375 million, five-year grant to the Hepatitis B Foundation to continue leading and expanding Hep B United, a nationwide coalition that operates in collaboration with the Association of Asian Pacific Community Health Organizations. Please read more here.
Hepatitis B Foundation Members Selected to Participate as Consumer Reviewers in the Congressionally Directed Medical Research Program’s Peer Reviewed Medical Research Program for the U.S. Department of Defense
Aug. 2, 2021 – The Congressionally Directed Medical Research Program’s (CDMRP), Peer Reviewed Medical Research Program (PRMRP) for the U.S. Department of Defense has selected consumer advocates nominated by the Hepatitis B Foundation. Please read more here.
Hepatitis B Foundation launches first global registry of discrimination against people living with hepatitis B
May 13, 2021 – People globally who are living with hepatitis B often experience discrimination in variety of ways, including denial of access to employment and education, even in the U.S., and an American nonprofit organization has launched the world’s first initiative to track and analyze that discrimination. Please read more here.
Hepatitis B Foundation supports launch of new global online forum dedicated to supporting people with hepatitis B, connecting with health experts
April 13, 2021 – The Hepatitis B Foundation is pleased to support the official launch of HepBcommunity.org, a new global online forum dedicated to supporting those living with and affected by hepatitis B. Please read more here.
Hepatitis B Foundation to hold its annual Crystal Ball Gala on April 30
April 8, 2021 – Our annual Crystal Ball Gala later this month holds a special significance: it is the ceremonial start of the Foundation's 30th Anniversary celebration. Please read more here.
Hepatitis B Foundation mourns the passing of John C. Martin, pharmaceutical industry leader
April 1, 2021 - The leadership and staff of the Hepatitis B Foundation share a high regard for John C. Martin, PhD, former CEO of Gilead Sciences Inc., who died suddenly this week. Please read more here.
Chronic hepatitis B is far more prevalent among U.S. residents than previously reported
March 10, 2021 – The number of adults living in the U.S. who have chronic hepatitis B infection may be as high as 2.4 million, which is nearly three times greater than the federal government’s official estimate, according to a new analysis by a team of public health experts, scientists and physicians. Please read more here.
Hepatitis B Foundation mourns loss of co-founder Paul Witte
Feb. 15, 2021 The Hepatitis B Foundation announces with great sadness the passing of Mr. Paul Witte, 94. An award-winning industrial and product-design engineer, Paul never hesitated to share his talents and resources to help create the Foundation as an important advisor and generous philanthropist. Please read more here.
All of Us research program
Feb. 15, 2021 – From 2020-2021, the proportion of Asian American and Pacific Islander communities represented in biomedical research has doubled, growing from 2% to 4%. The All of Us Research Program wants to encourage this valuable trend going. Please read more here.
Hepatitis B Foundation launches continuing education series on hepatitis B for health care providers and public health professionals
Feb. 5, 2021 – The Hepatitis B Foundation has launched Hep B Project ECHO Philadelphia, a continuing education series for health care providers and public health professionals using the ECHO Model™ to deliver educational content about hepatitis B to physicians, nurses, pharmacists, public health coordinators and other health care professionals. Please read more here.
Hepatitis B Foundation applauds release of National Hepatitis Strategic Plan
Jan. 7, 2021 – Today the U.S. Department of Health and Human Services (HHS) released the Viral Hepatitis National Strategic Plan, which provides a roadmap toward the elimination of viral hepatitis in the U.S. (2021-2025), including key objectives and strategies to eliminate hepatitis B and related health inequities. Please read more here.
Bristol Myers Squibb provides grant for work to reduce disparities in liver cancer for high-risk minority groups in the U.S.
Dec. 22, 2020 – Bristol Myers Squibb has awarded a one-year, $134,000 grant to the Hepatitis B Foundation to close the disparity gaps related to hepatitis B-associated liver cancer in the United States among Asian Americans, Pacific Islanders, African immigrant communities and other high-risk groups. Please read more here.
Federal Task Force Recommendation for Hepatitis B Screening Fails to Close Gaps in Diagnosis Rates
Dec. 16, 2020 – The Hepatitis B Foundation today released the following statement regarding the recent publication of a new statement from the U.S. Preventive Services Task Force (USPSTF). Please read more here.
Hepatitis B community leaders convene to address eliminating hepatitis B during COVID-19 pandemic
Nov. 30, 2020 – Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, will host its eighth annual (and first virtual) summit Dec. 2-4. Please read more here.
Hepatitis B Foundation announces 2021 Baruch S. Blumberg Prize
Nov. 12, 2020 -- The Hepatitis B Foundation is announcing today (Nov. 12) that Wenhui Li, Ph.D., has been chosen as the recipient of its 2021 Baruch S. Blumberg Prize for outstanding contributions to advance the science and medicine of hepatitis B. Please read more here.
Hepatitis B Foundation applaud HHS letter on discrimination against people living with hepatitis B pursing careers in health care
Nov. 6, 2020 - The Hepatitis B Foundation applauds the U.S. Department of Health and Human Services (HHS) for issuing a letter to health professions schools in the U.S., calling for renewed attention to admissions and clinical placement policies and their obligation to comply with federal civil rights laws that protect the rights of people living with hepatitis B. Please read more here.
Major new award to be presented to our co-founders Joan and Timothy Block
Nov. 4, 2020 - Hepatitis B Foundation co-founders Joan Block, R.N., and Timothy M. Block, Ph.D., will be receiving a very significant honor in November during The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases. The Association recently announced that, during the Nov. 13-16 Liver Meeting Digital Experience, the Blocks will receive the inaugural Distinguished Advocacy Service Award. Please read more here.
Hepatitis B Foundation launches new tool to assist people living with hepatitis B in making decisions on health insurance
Oct. 29, 2020 - The Hepatitis B Foundation today released a new report, Health Insurance Costs Impacting Shoppers Living with Hepatitis B, that is designed to help those living with chronic hepatitis B and their caregivers make better-informed decisions when choosing health insurance plans. Please read more here.
Hepatitis B Foundation releases report on first-ever Externally Led Patient-Focused Drug Development meeting for hepatitis B
Oct. 27, 2020 - In cooperation with the U.S. Food and Drug Administration (FDA), the Hepatitis B Foundation hosted an Externally Led Patient-Focused Drug Development (PFDD) meeting focused on hepatitis B on June 9, 2020. Today, the Foundation released its comprehensive report on the information-gathering event. Please read more here.
Hepatitis B Foundation launches B the Voice Story Bank
Aug. 18, 2020 – The Hepatitis B Foundation today is launching its new B the Voice Story Bank, an initiative to gather the stories of people around the world affected by hepatitis B. Please read more here.
Hepatitis B Foundation expresses appreciation for the work of Dr. Ding-Shinn Chen with the announcement of his death
June 25, 2020 - The Hepatitis B Foundation today is expressing its profound sadness at the passing of Dr. Ding-Shinn Chen, distinguished professor of the National Taiwan University College of Medicine. Please read more here.
Hepatitis B Foundation and Hep B United Statement on the Federal Government’s Rollback of Critical Health Care Protections
June 16, 2020: The U.S. Department of Health and Human Services (HHS) finalized a rule last week to roll back critical nondiscrimination protections provided under Section 1557 of the Affordable Care Act (ACA). Please read more here.
Two Powerful Editorial Published by the Hepatitis B Foundation
May 30, 2020: Two Powerful Editorial Published by the Hepatitis B Foundation. Please read them here.
HBF to host first-ever online Externally Led Patient-Focused Drug Development meeting
May 28, 2020: In cooperation with the FDA, the Hepatitis B Foundation will host an online Externally Led Patient-Focused Drug Development meeting for those living with hepatitis B and other key stakeholders on June 9 from 12:30-4:30 p.m. EDT. Please read more here.
Leading the way to 2030
May 27, 2020: "Leading the Way to 2030" is the theme of our recently released 2019 Annual Report. Please take a few minutes to review the report, posted here.
Rhea Racho named as a Health Hero!
May 15, 2020: Congratulations to Rhea Racho, Hepatitis B Foundation public policy and program manager, who has been named an AANHPI Health Hero by AAPCHO! Please read more here.
Hepatitis B Foundation Expands Hepatitis B Prevention Policy Initiatives
May 6, 2020: The Hepatitis B Foundation has launched a new Hepatitis B Prevention Policy Program aimed at increasing adult hepatitis B vaccination rates in the U.S. The program will build and expand the Foundation’s policy and advocacy initiatives and increase engagement with federal and state public health agency partners to improve hepatitis B prevention and vaccination infrastructure and strategies. Please read more here.
HHBV Vaccinations Save Lives, Reduce New Infections: National Adult Hepatitis B Vaccination Awareness Day
April 30, 2020: Only one quarter of U.S. adults ages 19 and older are fully vaccinated against hepatitis B, despite the availability of a safe and effective vaccine for more than 30 years. Today, on National Adult Hepatitis B Vaccination Awareness Day, we are calling for an increased commitment to improving adult hepatitis B vaccination coverage in the United States to reduce the number of new hepatitis B infections and hepatitis B-related deaths. Please read more here.
Hepatitis B Foundation Says "Thank You!" to its 100-plus Volunteers
April 22, 2020: During National Volunteer Week in the United States, the Hepatitis B Foundation is publicly thanking its more than 100 volunteers worldwide. Those dedicated individuals work with the Foundation to help serve people living with hepatitis B, their families and health care providers, sharing information about the resources available to them, particularly about the treatment and prevention of the infectious disease. Please read more here.
Hepatitis B Foundation Announces Annual Fundraising Event to Go Virtual April 24
April 8, 2020: In this challenging time, the Hepatitis B Foundation continues to serve people living with hepatitis B, their families and health care providers, and planning continues for its principal annual fundraiser. The foundation is adapting its 2020 Crystal Ball Gala from an in-person event to our first “Pajama Gala.” Please read more here.
Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center Announce New Director of Communications and Marketing
April 8, 2020: The Hepatitis B Foundation recently appointed Edward F. Tate III, a Newtown resident, as director of communications and marketing. Along with leading the foundation’s communications and marketing, Tate also will handle those functions for the Baruch S. Blumberg Institute and the Pennsylvania Biotechnology Center (PABC). Please read more here.
Hepatitis B Foundation Strongly Supports the Strategic Plan for Trans‐NIH Research to Cure Hepatitis B
Dec. 11, 2019: The National Institutes of Health (NIH) released a groundbreaking Strategic Plan for Trans‐NIH Research to Cure Hepatitis B on Dec. 10. This Plan is the first product from the NIH Hepatitis B Cure Strategic Plan Working Group that was created as a result of Fiscal Year 2019 Congressional Appropriations Report language advocated for by the Hepatitis B Foundation. Please read more here.
Hepatitis B Foundation Announces 2020 Baruch S. Blumberg Prize Winner
Nov. 18, 2019: The Hepatitis B Foundation has named John Taylor, PhD, the recipient of its 2020 Baruch S. Blumberg Prize for excellence in hepatitis B research. Dr. Taylor is a Professor Emeritus at Fox Chase Cancer Center in Philadelphia. Please read more.
Hepatitis B Foundation Plans Externally-Led Patient-Focused Drug Development Meeting for Chronic Hepatitis B in June 2020
Nov. 6, 2019: The Hepatitis B Foundation is pleased to have been approved by the U.S. Food and Drug Administration (FDA) to host an externally-led Patient-Focused Drug Development (PFDD) meeting on June 9, 2020 that will focus on chronic hepatitis B infection (CHB). Read more.
U.S. Falls Short in Reaching 2020 Goals for Hepatitis B
Sept. 18, 2019: The U.S. is falling short of targets for hepatitis B vaccination, and for reducing new hepatitis B cases, according to the 2019 National Viral Hepatitis Progress Report, released this week by the Centers for Disease Control and Prevention (CDC). Read more.
Hepatitis B Foundation Calls for Increased Resources for Hepatitis B Prevention in Response to CDC 2017 Surveillance Data Report
Sept. 11, 2019: The Hepatitis B Foundation is calling for increased resources to improve hepatitis B vaccination rates and educate high-risk communities, in response to newly-released viral hepatitis surveillance data from the Centers for Disease Control and Prevention (CDC). Read more.
Our Voices Made a Difference: CVS Caremark to Cover Vemlidy Prescriptions
Sept. 9, 2019: The Hepatitis B Foundation, along with our network of patients, providers and partners, has successfully advocated for improved access to the hepatitis B medication Vemlidy in the US. Read more.
Hepatitis B Foundation Commends New Rx Outreach Program to Provide Access to Affordable Hepatitis B Medication
The Hepatitis B Foundation commends Rx Outreach, a nonprofit online pharmacy, for expanding their service to provide medications to help more than 2 million Americans who are chronically infected with hepatitis B. Read more.
Hepatitis B Foundation Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2019
The Hepatitis B Foundation (HBF) strongly endorses yesterday’s re-introduction of the Liver Illness Visibility, Education and Research (LIVER) Act of 2019 (HR 3016). Read more.
2018 Press Releases
Hepatitis B Foundation Announces 2019 Baruch S. Blumberg Prize Winner
The Hepatitis B Foundation has named Christoph Seeger, PhD, the recipient of its 2019 Baruch S. Blumberg Prize for excellence in hepatitis B research. Dr. Seeger will receive his award at the 2019 Crystal Ball Gala on April 26, 2019. Read more.
Hep B United Applauds Bipartisan Legislation to Combat Opioid Crisis and Opioid Related Infectious Diseases
Hep B United today released the following statement, commending Congress for working together to pass the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. The legislation was signed into law by the president, following overwhelming bipartisan Congressional support. Read more
Hepatitis B Foundation Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2018
The Hepatitis B Foundation (HBF) strongly endorses the introduction the Liver Illness Visibility, Education and Research (LIVER) Act of 2018. Introduced by Representative Nydia Velazquez (D-NY), the bill takes bold steps to increase investments in research, prevention, and awareness activities to address hepatitis B. Read more.
Hepatitis B Foundation Calls for Universal Screening for Hepatitis B
In recognition of World Hepatitis Day on July 28, the Hepatitis B Foundation (HBF) is calling for all Americans to be tested for hepatitis B infection. The formal recommendation was approved by HBF’s Scientific and Medical Advisory Board to achieve the World Health Organization’s (WHO) ambitious goal of eliminating hepatitis B by the year 2030. Read more.
Hepatitis B Leaders Call for the Elimination of Hepatitis B
Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, hosts its sixth annual summit in Washington, D.C., July 24 to 26. The summit brings together community leaders, advocates and people with hepatitis B to promote screening and prevention strategies and advocate for equitable access to health care to further its mission to eliminate hepatitis B in the United States. Read more.
Hepatitis B Foundation Releases New #justB Stories to Empower People Affected by Hepatitis B, Raise Awareness and End Stigma
The Hepatitis B Foundation released seven new videos as part of its national #justB storytelling campaign, which was launched one year ago to highlight the personal stories of people from across the United States who have been affected by hepatitis B. Read more
Hepatitis B Foundation Honors Business Leader Fred Beans and Scientist Ding-Shinn Chen at its 2018 Crystal Ball Gala
The Hepatitis B Foundation (HBF) hosted over 230 leaders from academia, industry, government and the community at its annual Crystal Ball Gala on April 6, 2018 at Pinecrest Country Club in Lansdale, PA. Read more.
New Two-Dose HBV Vaccine Recommended by ACIP
February 22, 2018: The Advisory Committee on Immunization Practices’ (ACIP) voted today to unanimously recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV). The Hepatitis B Foundation welcomes the use of the new vaccine, which is expected to increase immunization rates for adults in the United States. Read more.
Timothy M. Block, PhD, President of Hepatitis B Foundation and its Baruch S. Blumberg Institute, named a 2017 National Academy of Inventors Fellow 2017
December 12, 2017: Timothy M. Block, Ph.D, has been named a Fellow of the US National Academy of Inventors (NAI), the organization announced Tuesday. Dr. Block is President of the Hepatitis B Foundation, as well as its research arm, the Baruch S. Blumberg Institute, and its Pennsylvania Biotechnology Center. Read more.
Hepatitis B Foundation Applauds FDA Approval of New Hepatitis B Vaccine
November 2017: Today on World Immunization Day, the Hepatitis B Foundation applauded the U.S. Food and Drug Administration’s (FDA) approval of HEPLISAV-B™, the first new hepatitis B vaccine in more than 25 years and the only two-dose schedule for the prevention of infection in adults. Read more.
CDC National Progress Report on Hepatitis Elimination Reveals Rise in Acute HBV Infections and Low Birth Dose Vaccination Rates in the U.S.
October 2017: The Hepatitis B Foundation statement on the CDC's national progress report on viral hepatitis elimination in the U.S., which measures progress toward 2020 goals. Read more.
Hepatitis B Foundation Announces Promotion of Chari Cohen, DrPH, MPH, to Vice President, Public Health and Programs
October 2017: The Hepatitis B Foundation, a national nonprofit organization headquartered in Doylestown, PA, has announced the promotion of Chari Cohen, DrPH, MPH to vice president, public health and programs. Read more.
Hepatitis B Foundation Mourns the Loss of Pioneering Hepatitis B Physician-Scientist Dr. W. Thomas London
June 2017: W. Thomas London, MD, an internationally renowned physician-scientist dedicated to the study of hepatitis B, passed away June 3 at the age of 85. Dr. London was a key member of the research team that discovered the hepatitis B virus in the early 1960s, and longtime member of the Board of the Hepatitis B Foundation and its research arm, the Baruch S. Blumberg Institute, where he also served as a distinguished scientific and medical advisor. Read more.
Hepatitis B Foundation Launches Hep B Cure Campaign for Increased NIH Funding
May 2017: The Hepatitis B Foundation launches its national Hep B Cure Campaign, which features a consensus research agenda that outlines top scientists’ priority research recommendations for hepatitis B and liver cancer. Read more.
Hepatitis B Foundation's #justB Campaign Gives Voice to Personal Stories During May Hepatitis Awareness Month
May 2017: The Hepatitis B Foundation has launched its innovative #justB Storytelling Campaign to highlight the personal stories of people affected by hepatitis B to capture public attention during May Hepatitis Awareness Month. Read more.
Hepatitis B Foundation Executive Director Retires After 25 Years of Service
April 2017: Co-founder Joan Block helped create the nation’s leading nonprofit research and disease advocacy organization dedicated to hepatitis B. Read more.
Hepatitis B Foundation Commends Targets to Eliminate Hepatitis B in U.S.
March 2017: The Hepatitis B Foundation commends the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM) report, A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report, that concludes a 50 percent reduction in mortality from chronic hepatitis B infection, as well as elimination of mother-to-child transmission of hepatitis B, is possible in the United States by 2030with appropriate prioritization and resources. Read more.
Hepatitis B Foundation and HBV Forum Summary Report of Meeting with US FDA
March 2017: Representatives from the Hepatitis B Foundation and HBV Forum met with representatives from the US FDA to discuss clinical development of hepatitis B therapeutics. Read the meeting summary.
Fred Beans Family of Dealerships Donates $30,000 to Support the Hepatitis B Foundation's High School Enrichment Programs
February 2017: The Hepatitis B Foundation’s (HBF) High School Science Enrichment Program received a $30,000 donation from the Fred Beans Family of Dealerships to support its research program for outstanding high school students. Read more.
Hepatitis B Foundation Welcomes International Leaders to Its Scientific and Medical Advisory Board
February 2017: The Hepatitis B Foundation is pleased to announce that two internationally renowned experts in the area of viral hepatitis have joined its Scientific and Medical Advisory Board. Read more.
Hepatitis B Foundation Appoints Global Expert Dr. Nat Brown to Its Board of Directors
February 2017: The Hepatitis B Foundation, the nation’s leading nonprofit research and disease advocacy organization, is pleased to announce the appointment of Nathaniel Brown, M.D., a retired pharmaceutical executive living in San Francisco, to its Board of Directors. Read more.
Hepatitis B Foundation Launches #justB Storytelling Campaign
January 2017: The Hepatitis B Foundation unveils its #justB national storytelling campaign with real people sharing their stories about hepatitis B. The goal is to put a human face on this disease in order to increase public awareness, decrease stigma and discrimination, and to promote testing and treatment for hepatitis B, which will ultimately save lives. Read more.
World-Renowned Cancer Physician Scientist Dr. Richard G. Pestell Joins the Baruch S. Blumberg Institute
January 2017: World-renowned cancer physician scientist Richard G. Pestell, M.D., Ph.D., has joined the Baruch S. Blumberg Institute to serve as President of the Pennsylvania Cancer and Regenerative Medicine Research Center (PCARM). Read more.
Hepatitis B Research Pioneer Dr. Bud Tennant Leaves Behind a Distinguished Scientific Legacy
Nov. 2016: Bud C. Tennant, DVM, a pioneer in developing the woodchuck animal model for the study of hepatitis B, and distinguished member of the Hepatitis B Foundation’s Scientific and Medical Advisory Board, passed away on November 16. Read more.
Hepatitis B Foundation Co-Sponsors East Coast Film Premiere of Be About It
Nov. 2016: Documentary about two families profoundly affected by hepatitis B will show at Philadelphia Asian American Film Festival on November 20. Read more.
Hepatitis B Foundation Launches Nationwide Hepatitis Delta Virus (HDV) Campaign to Expand Awareness and Testing for HDV Infection
Oct. 2016: Collaboration with Eiger Biopharma and ARUP Laboratories Focuses on Deadly Form of Viral Hepatitis. Read more.
Living with Hepatitis B: Hepatitis B Foundation Launches Patient Storytelling Campaign
October 2016: National nonprofit creates program to help people living with hepatitis B share their stories. Read more.
Hepatitis B Foundation Applauds CMS Final Decision to Cover Hepatitis B Screening
September 2016: Hepatitis B screening test added as a preventive service for Medicare beneficiaries. Read more.
Hepatitis B Foundation Launches Comprehensive New Website to Celebrate 25th Anniversary
September 2016: National nonprofit’s new website offers improved user experience, simplified navigation as a trusted global authority for information about hepatitis B. Read more.
Baruch S. Blumberg Institute Congratulates Michael J. Sofia on Receiving the 2016 Lasker-DeBakey Clinical Medical Research Award
September 2016: Blumberg Institute professor receives celebrated scientific honor for his discovery of the cure for chronic hepatitis C infection. Read more.
Hepatitis B Foundation Partners with Eiger BioPharmaceuticals to Raise Awareness of Hepatitis Delta Virus Co-Infection
August 2016: Occurring only in those already infected with hepatitis B, hepatitis delta can lead to more severe liver disease than HBV alone. Read more.
‘Making the Link’ Between Viral Hepatitis and Liver Cancer
July 2016: Hepatitis B Foundation to urge Philadelphia city leaders to help decrease liver cancer rates by making chronic HBV and HCV testing and treatment a local priority. Read more.
Hepatitis B Foundation Marks 25th Anniversary at 2016 Crystal Ball Gala
April 2016: Annual event raises nearly $125,000 for research and outreach to eliminate hepatitis B that affects more than 12 million Americans and 2 billion people worldwide. Read more.
Hepatitis B Foundation’s ‘Nobel Challenge’ Raises $3 Million to Support Research for a Cure
Jan. 26 – The Hepatitis B Foundation announces the successful completion of its “Nobel Challenge” campaign, raising more than $3 million to recruit top scientists to its affiliated Baruch S. Blumberg Institute to fulfill its research mission - to find a cure for hepatitis B. Read more.
Baruch S. Blumberg Institute Partners with The Commonwealth Medical College to Offer Innovative Graduate Program
Jan. 14 - The Baruch S. Blumberg Institute, established by the Hepatitis B Foundation, announced today it will partner with The Commonwealth Medical College to offer the first life sciences graduate program in Bucks County, PA. Working professionals will be able to earn a Master's degree in Biological Sciences in 16 months during evening and weekend classes at the Blumberg Institute in Doylestown, PA. Read more.
Hepatitis B Foundation Leaders Help Shape National Plan to Eliminate Hepatitis B and C
Jan. 11, 2016 - Drs. Robert Gish and Chari Cohen of the Hepatitis B Foundation provide expert testimony to the National Academy of Medicine in support of a national strategy to eliminate chronic viral hepatitis in the United States by 2030. Read more.
Journal of the National Cancer Institute (JNCI) Publishes Summary of Hepatitis B Foundation’s Liver Cancer Workshop
Dec. 2015 - The JNCI paper submitted by the Hepatitis B Foundation in collaboration with thought leaders in the field focused on improving screening and care for those with liver cancer related to chronic hepatitis B infections. The article, “Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care,” has been published online and will appear in the NCI Journal’s print issue in April 2016. Read more.
The W. Thomas London Distinguished Professorship Established by the Hepatitis B Foundation and Baruch S. Blumberg Institute
Oct. 2015 - The named Professorship honors Dr. W. Thomas London (on left) who made transformational contributions to the discovery of the hepatitis B virus with Dr. Baruch Blumberg and dedicated his career to the study of the virus and care of those affected. Dr. Ju Tao Guo (on right) is the inaugural recipient of the new professorship. He serves as director of Experimental Therapeutics at the Baruch S. Blumberg Institute, which was established by the Hepatitis B Foundation to fulfill its research mission. Read more.
2015 Press Releases
Dr. Eugene Schiff Receives Hepatitis B Foundation’s Highest Scientific Honor
April 20 – The 2015 Crystal Ball Gala, hosted by the Hepatitis B Foundation, was a huge success, and included an evening of dinner, dancing, live and silent auctions, a mission moment, and the awarding of the Baruch S. Blumberg Prize to Dr. Eugene Schiff for advancing the care and treatment of chronic hepatitis B. Read more.
Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists
March 2015 – The Baruch S. Blumberg Institute (www.blumberginstitute.org) has recruited a new team of nationally renowned scientists to focus exclusively on research to develop a cure for hepatitis B, a move that nearly triples its research capacity and has created the largest concentration of nonprofit scientists focusing solely on hepatitis B and liver cancer in the United States. Read more.